P.M. Christensen
Department of Clinical Pharmacology
Institute of Medical Biology
Odense University
Denmark
Name/email consistency: high
- The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis. Christensen, P.M., Gøtzsche, P.C., Brøsen, K. Pharmacogenetics (1998)